Participated in Integrated Biosciences' $17.2M seed financing for synthetic-biology and AI drug discovery.
Integrated Biosciences is engineering the future of aging medicine by advancing research at the intersection of synthetic biology, chemistry, and computation, focusing on drug discovery and development to combat age-related diseases
Integrated Biosciences is engineering the future of aging medicine by advancing research at the intersection of synthetic biology, chemistry, and computation, focusing on drug discovery and development to combat age-related diseases.